Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Almirall ( (ES:ALM) ).
Almirall will host a webcast for analysts and institutional investors to present and discuss its financial results for the first quarter of 2026, scheduled for 11 May at 10:00 a.m. CET. The event, which underscores the company’s ongoing investor-relations efforts and commitment to transparency, will be streamed live on its corporate website, where a full recording will also be made available for later viewing.
By facilitating direct access to management’s commentary on quarterly performance, the webcast aims to maintain engagement with the financial community and support informed investment decisions. This type of regular communication helps reinforce Almirall’s positioning in the pharmaceutical sector as it navigates market expectations and operational developments through 2026.
The most recent analyst rating on (ES:ALM) stock is a Hold with a EUR14.00 price target. To see the full list of analyst forecasts on Almirall stock, see the ES:ALM Stock Forecast page.
More about Almirall
Almirall, S.A. is a Barcelona-based pharmaceutical company focused on developing and commercializing medicines, with a particular emphasis on prescription treatments. The company targets healthcare professionals, patients, and institutional investors in markets where innovative therapies and clinical performance are key competitive drivers.
Average Trading Volume: 149,849
Technical Sentiment Signal: Buy
Current Market Cap: €2.57B
Find detailed analytics on ALM stock on TipRanks’ Stock Analysis page.